April 22, 2020
The FDA continues to update its FAQs on COVID-19 testing.
As of April 21, 2020, the FDA had 43 EUAs for test kits manufacturers and commercial laboratories. In addition, the FDA granted EUAs for 17 high complexity molecular-based laboratory developed tests.
Finally, on April 21, 2020, the FDA authorized its first diagnostic test with an at-home collection option for COVID-19.